105 studies on IGF-1 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Growth Guys Canada | 2 | 99.46% | View COA → |
Recent certificates: #15360 (98.134%) · #20106 (98.134%) · #23248 (99.456%) · #23216 (99.563%) · #18332 (99.139%) · #17858 (99.282%)
Manufacturers with published third-party certificates of analysis for IGF-1. Open a vendor to see every batch we've verified.
These findings suggest that Ipamorelin could be a promising therapeutic agent for conditions characterized by growth hormone deficiency, sarcopenia, or osteoporosis. Its selective action as a growth hormone secretagog…
This hypothetical study highlights CJC-1295's potential as a long-acting growth hormone-releasing hormone (GHRH) analog, capable of providing sustained GH and IGF-1 elevation from a single dose. This sustained release…
If the trial yielded positive results, this study would validate an oral therapeutic approach for fibromyalgia, potentially offering a more convenient and accessible alternative to injectable growth hormone. An effect…
The widespread and increasing misuse of peptides poses a significant threat to the integrity of sports and the long-term health of athletes. This comprehensive review provides crucial insights for anti-doping organiza…
Free, no account — handy when you're working with IGF-1.